Page last updated: 2024-10-31

nafronyl and Bronchitis

nafronyl has been researched along with Bronchitis in 1 studies

Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.

Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Williams, AJ1
Osman, J1
Skinner, C1

Trials

1 trial available for nafronyl and Bronchitis

ArticleYear
Effects of naftidrofuryl on breathlessness and exercise tolerance in chronic bronchitis.
    Thorax, 1982, Volume: 37, Issue:8

    Topics: Aged; Bronchitis; Chronic Disease; Female; Furans; Humans; Lung; Male; Middle Aged; Nafronyl; Physic

1982